Diagnostic modalities in peripheral artery disease. (April 2018)

• Record Type: Journal Article
• Authors: Vlachopoulos, Charalambos; Georgakopoulos, Christos; Koutagiar, Iosif; Tousoulis, Dimitrios
• Is Part Of: Current opinion in pharmacology. Volume 39(2018)
• Page Start: 68
• Page End: 76
• Publication Date: 2018-04
• Subjects: Pharmacology -- Periodicals; Pharmaceutical Preparations -- Periodicals; Drug Therapy -- Periodicals; Biopharmaceutics -- Periodicals; Pharmacologie -- Périodiques; Pharmacology; Periodicals; 615.105
• DOI: 10.1016/j.coph.2018.02.010
• Languages: English
• ISSNs: 1471-4892

Abstract

Highlights: ABI is a well-established risk predictor. DUS is often the first-line test both for screening and diagnosis of PAD. In asymptomatic patients with carotid artery stenosis 60–99%, DUS could identify patients suitable for CEA. CTA and MRA provide with a 'roadmap' of the vascularization. Digital subtraction angiography has been mostly replaced by other less invasive methods except for below-the-knee arterial disease. Abstract : Peripheral artery disease (PAD) affects approximately one in five persons older than 70 years of age and it is often present in patients with concomitant vascular disease in different body territories (e.g. coronary artery disease). Diagnosis at an early stage is important in order to achieve improvement in patient's symptoms and prognosis. Remarkable improvements in the field of noninvasive and invasive imaging techniques have led to an advanced level the management of patients with PAD. Throughout this review article, the clinically available diagnostic modalities in PAD are presented. Strong and weaker points are stressed out in a manner that elucidates that no perfect diagnostic method exists. Based on the patient's individual profile, as well as on certain aspects of the disease (e.g. morphology of carotid plaque lesions) the attending physician will ultimately decide which diagnostic path will lead to a prompt and correct diagnosis of PAD with the minimum amount of exams and risk for the patient.